Also see: Aetna, Bristol-Myers: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.



) --



(BID) - Get Report

estimates, target raised at Stifel. Shares of BID now seen reaching $58. Estimates also increased, given higher sales in Hong Kong and New York. Buy rating.


(EXPE) - Get Report

estimates, target cut at UBS. Shares of EXPE now seen reaching $25. Estimates also lowered, given lower expected bookings.

Family Dollar


numbers raised at Goldman. Shares of FDO now seen reaching $55, according to Goldman Sachs. Estimates also increased, as the company is realizing higher sales. Neutral rating.


(IEX) - Get Report

estimates upped at Jefferies through 2012. Channel checks suggest that sales trends are improving. Buy rating and $54 price target.


(INTC) - Get Report

estimates, target lowered at FBR. INTC estimates were cut through 2012, FBR Capital Markets said. Recent checks suggest that notebook demand is waning. Market Perform rating and new $25 price target.


(LYB) - Get Report

estimates, target boosted at Jefferies. Shares of LYB now seen reaching $50, according to Jefferies. Estimates also upped, as the company can continue to expand margins. Buy rating.

Morgan Stanley

(MS) - Get Report

estimates lowered at Ticonderoga through 2012, Ticonderoga Securities said. Company will likely face weaker trading results. Positive rating.

Procter & Gamble

(PG) - Get Report

estimates reduced at Goldman through 2013. Company is facing higher commodity costs. Buy rating and $75 price target.

Success Factors


target increased at Morgan Stanley to $45. Company can exceed its billings growth guidance. Overweight rating.

End of report.

This article was written by a staff member of TheStreet.